347 related articles for article (PubMed ID: 21990351)
1. Targeting Acyl-CoA:diacylglycerol acyltransferase 1 (DGAT1) with small molecule inhibitors for the treatment of metabolic diseases.
Cao J; Zhou Y; Peng H; Huang X; Stahler S; Suri V; Qadri A; Gareski T; Jones J; Hahm S; Perreault M; McKew J; Shi M; Xu X; Tobin JF; Gimeno RE
J Biol Chem; 2011 Dec; 286(48):41838-41851. PubMed ID: 21990351
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological characterization of [trans-5'-(4-amino-7,7-dimethyl-2-trifluoromethyl-7H-pyrimido[4,5-b][1,4]oxazin-6-yl)-2',3'-dihydrospiro(cyclohexane-1,1'-inden)-4-yl]acetic acid monobenzenesulfonate (JTT-553), a novel acyl CoA:diacylglycerol transferase (DGAT) 1 inhibitor.
Tomimoto D; Okuma C; Ishii Y; Akiyama Y; Ohta T; Kakutani M; Ohkuma Y; Ogawa N
Biol Pharm Bull; 2015; 38(2):263-9. PubMed ID: 25747985
[TBL] [Abstract][Full Text] [Related]
3. Increased insulin and leptin sensitivity in mice lacking acyl CoA:diacylglycerol acyltransferase 1.
Chen HC; Smith SJ; Ladha Z; Jensen DR; Ferreira LD; Pulawa LK; McGuire JG; Pitas RE; Eckel RH; Farese RV
J Clin Invest; 2002 Apr; 109(8):1049-55. PubMed ID: 11956242
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological inhibition to examine the role of DGAT1 in dietary lipid absorption in rodents and humans.
Maciejewski BS; LaPerle JL; Chen D; Ghosh A; Zavadoski WJ; McDonald TS; Manion TB; Mather D; Patterson TA; Hanna M; Watkins S; Gibbs EM; Calle RA; Steppan CM
Am J Physiol Gastrointest Liver Physiol; 2013 Jun; 304(11):G958-69. PubMed ID: 23558010
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of thiazole containing biaryl analogs as diacylglycerol acyltransferase 1 (DGAT1) inhibitors.
Kadam KS; Jadhav RD; Kandre S; Guha T; Reddy MM; Brahma MK; Deshmukh NJ; Dixit A; Doshi L; Srinivasan S; Devle J; Damre A; Nemmani KV; Gupte A; Sharma R
Eur J Med Chem; 2013 Jul; 65():337-47. PubMed ID: 23735282
[TBL] [Abstract][Full Text] [Related]
6. Suppression of diacylglycerol acyltransferase-2 (DGAT2), but not DGAT1, with antisense oligonucleotides reverses diet-induced hepatic steatosis and insulin resistance.
Choi CS; Savage DB; Kulkarni A; Yu XX; Liu ZX; Morino K; Kim S; Distefano A; Samuel VT; Neschen S; Zhang D; Wang A; Zhang XM; Kahn M; Cline GW; Pandey SK; Geisler JG; Bhanot S; Monia BP; Shulman GI
J Biol Chem; 2007 Aug; 282(31):22678-88. PubMed ID: 17526931
[TBL] [Abstract][Full Text] [Related]
7. A novel coenzyme A:diacylglycerol acyltransferase 1 inhibitor stimulates lipid metabolism in muscle and lowers weight in animal models of obesity.
Yamamoto T; Yamaguchi H; Miki H; Kitamura S; Nakada Y; Aicher TD; Pratt SA; Kato K
Eur J Pharmacol; 2011 Jan; 650(2-3):663-72. PubMed ID: 21034741
[TBL] [Abstract][Full Text] [Related]
8. Intestine-targeted DGAT1 inhibition improves obesity and insulin resistance without skin aberrations in mice.
Tsuda N; Kumadaki S; Higashi C; Ozawa M; Shinozaki M; Kato Y; Hoshida K; Kikuchi S; Nakano Y; Ogawa Y; Furusako S
PLoS One; 2014; 9(11):e112027. PubMed ID: 25405858
[TBL] [Abstract][Full Text] [Related]
9. Intestinal DGAT1 deficiency reduces postprandial triglyceride and retinyl ester excursions by inhibiting chylomicron secretion and delaying gastric emptying.
Ables GP; Yang KJ; Vogel S; Hernandez-Ono A; Yu S; Yuen JJ; Birtles S; Buckett LK; Turnbull AV; Goldberg IJ; Blaner WS; Huang LS; Ginsberg HN
J Lipid Res; 2012 Nov; 53(11):2364-79. PubMed ID: 22911105
[TBL] [Abstract][Full Text] [Related]
10. Coenzyme A: diacylglycerol acyltransferase 1 inhibitor ameliorates obesity, liver steatosis, and lipid metabolism abnormality in KKAy mice fed high-fat or high-carbohydrate diets.
Yamamoto T; Yamaguchi H; Miki H; Shimada M; Nakada Y; Ogino M; Asano K; Aoki K; Tamura N; Masago M; Kato K
Eur J Pharmacol; 2010 Aug; 640(1-3):243-9. PubMed ID: 20478303
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological inhibition of diacylglycerol acyltransferase 1 reduces body weight gain, hyperlipidemia, and hepatic steatosis in db/db mice.
Zhang XD; Yan JW; Yan GR; Sun XY; Ji J; Li YM; Hu YH; Wang HY
Acta Pharmacol Sin; 2010 Nov; 31(11):1470-7. PubMed ID: 21052084
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of triglyceride synthesis as a treatment strategy for obesity: lessons from DGAT1-deficient mice.
Chen HC; Farese RV
Arterioscler Thromb Vasc Biol; 2005 Mar; 25(3):482-6. PubMed ID: 15569818
[TBL] [Abstract][Full Text] [Related]
13. Novel role of a triglyceride-synthesizing enzyme: DGAT1 at the crossroad between triglyceride and cholesterol metabolism.
Sachdev V; Leopold C; Bauer R; Patankar JV; Iqbal J; Obrowsky S; Boverhof R; Doktorova M; Scheicher B; Goeritzer M; Kolb D; Turnbull AV; Zimmer A; Hoefler G; Hussain MM; Groen AK; Kratky D
Biochim Biophys Acta; 2016 Sep; 1861(9 Pt A):1132-1141. PubMed ID: 27344248
[TBL] [Abstract][Full Text] [Related]
14. Mechanism of action for small-molecule inhibitors of triacylglycerol synthesis.
Sui X; Wang K; Song K; Xu C; Song J; Lee CW; Liao M; Farese RV; Walther TC
Nat Commun; 2023 May; 14(1):3100. PubMed ID: 37248213
[TBL] [Abstract][Full Text] [Related]
15. Dissociation of obesity and impaired glucose disposal in mice overexpressing acyl coenzyme a:diacylglycerol acyltransferase 1 in white adipose tissue.
Chen HC; Stone SJ; Zhou P; Buhman KK; Farese RV
Diabetes; 2002 Nov; 51(11):3189-95. PubMed ID: 12401709
[TBL] [Abstract][Full Text] [Related]
16. Diacylglycerol acyltransferase 1/2 inhibition induces dysregulation of fatty acid metabolism and leads to intestinal barrier failure and diarrhea in mice.
Takemoto K; Fukasaka Y; Yoshimoto R; Nambu H; Yukioka H
Physiol Rep; 2020 Aug; 8(15):e14542. PubMed ID: 32786057
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and evaluation of cyclohexane carboxylic acid head group containing isoxazole and thiazole analogs as DGAT1 inhibitors.
Kandre S; Bhagat PR; Reddy MM; Dalal R; Dixit A; Deshmukh NJ; Anthony J; Bose J; Anupindi R; Sharma R; Gupte A
Eur J Med Chem; 2014 May; 79():203-15. PubMed ID: 24735646
[TBL] [Abstract][Full Text] [Related]
18. Discovery of dimethyl pent-4-ynoic acid derivatives, as potent and orally bioavailable DGAT1 inhibitors that suppress body weight in diet-induced mouse obesity model.
Yu T; Wu C; Shih N; Li Q; Chan C; Pan H; Yao D; Pan Y; Liang W; Shen L; Zhao H; Li J; Chen S
Bioorg Med Chem Lett; 2018 Jun; 28(10):1686-1692. PubMed ID: 29699923
[TBL] [Abstract][Full Text] [Related]
19. Expression of DGAT2 in white adipose tissue is regulated by central leptin action.
Suzuki R; Tobe K; Aoyama M; Sakamoto K; Ohsugi M; Kamei N; Nemoto S; Inoue A; Ito Y; Uchida S; Hara K; Yamauchi T; Kubota N; Terauchi Y; Kadowaki T
J Biol Chem; 2005 Feb; 280(5):3331-7. PubMed ID: 15550388
[TBL] [Abstract][Full Text] [Related]
20. Intestine-specific expression of acyl CoA:diacylglycerol acyltransferase 1 reverses resistance to diet-induced hepatic steatosis and obesity in Dgat1-/- mice.
Lee B; Fast AM; Zhu J; Cheng JX; Buhman KK
J Lipid Res; 2010 Jul; 51(7):1770-80. PubMed ID: 20147738
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
